EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

In Vivo Evaluation of a Novel Long‐Term Intravascular Implantable Continuous Blood Glucose Monitor in an Ovine Model: A Glucotrack Inc. Investigation

Mark A Tapsak iD, Michael Talcott iD, James P Thrower iD, Paul V Goode, Timothy L Routh, Stephen T Tapsak iD, Jose Garcia iD

Journal of Diabetes Research · 2026-01 · 2026 (1)

DOI: 10.1155/jdr/8838426 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Diabetes Research, online erschienen am 25.04.2026. Verfasst von Mark A Tapsak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Glucotrack Inc., Front Royal, Virginia, USA. Hauptthemen laut MEDLINE: Continuous Glucose Monitoring, Blood Glucose. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Implantable intravascular continuous blood glucose monitors (CBGMs) offer a promising approach for accurately measuring glucose levels with short lag times and improved reliability when compared with conventional laboratory‐based point‐of‐care or handheld glucometers. In this study, 34 Glucotrack long‐term intravascular CBGM devices were implanted into 17 adult sheep, with one device placed in each jugular vein. Each implantation was completed in approximately 20 min and did not require any customized tools or techniques. Intravenous glucose tolerance tests (IVGTTs) were performed approximately monthly throughout the studies (30–240 days postimplantation) and mean absolute relative difference (MARD) values were calculated against an Accu‐Chek Guide handheld glucometer as the reference standard. The weighted average MARD was 6.84% for all 34 devices during a total of 79 IVGTTs. In addition, no device‐related adverse safety events were observed during this long‐term in vivo proof‐of‐concept evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Glucose MonitoringBlood GlucoseAnimalsSheepReproducibility of ResultsGlucose Tolerance TestJugular VeinsFemaleModels, Animal

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Research and Development, Glucotrack Inc., Front Royal, Virginia, USA.
  • Division of Cardiology, Washington University in St. Louis, St. Louis, Missouri, USA, wustl.edu.

ORCID-Profile: Mark A Tapsak, Michael Talcott, James P Thrower, Stephen T Tapsak, Jose Garcia

Zitieren

APA

Tapsak, M. A., Talcott, M., Thrower, J. P., Goode, P. V., Routh, T. L., Tapsak, S. T., & Garcia, J. (2026). In Vivo Evaluation of a Novel Long‐Term Intravascular Implantable Continuous Blood Glucose Monitor in an Ovine Model: A Glucotrack Inc. Investigation. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/8838426

Vancouver

Tapsak MA, Talcott M, Thrower JP, Goode PV, Routh TL, Tapsak ST, et al. In Vivo Evaluation of a Novel Long‐Term Intravascular Implantable Continuous Blood Glucose Monitor in an Ovine Model: A Glucotrack Inc. Investigation. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/8838426

BibTeX
@article{Tapsak2026,
  author = {Tapsak, Mark A and Talcott, Michael and Thrower, James P and Goode, Paul V and Routh, Timothy L and Tapsak, Stephen T and Garcia, Jose},
  title = {In Vivo Evaluation of a Novel Long‐Term Intravascular Implantable Continuous Blood Glucose Monitor in an Ovine Model: A Glucotrack Inc. Investigation},
  journal = {Journal of Diabetes Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jdr/8838426}
}
Kostenlos starten →